Gitnux/Report 2026

Proteomics Industry Statistics

See how proteomics is scaling from market revenue forecasts to public data volume with 35.93 billion in projected global proteomics market size by 2030 alongside ProteomeXchange backed growth that drove 19.3 million peptide spectrum matches into PRIDE. You will also get a clear signal for where spend is tightening and where it is surging, from TMT and PRM specificity and DIA scale to bioinformatics labor costs and rising regulatory momentum for biomarker linked therapies.
34Statistics
18Sources
5Sections
7mRead
May 15, 2026Updated
Proteomics Industry Statistics
Alexander SchmidtWritten by Alexander Schmidt·Edited by Marcus Afolabi·Fact-checked by Rajesh Patel
Published ·Updated
How this report is researched
01Editorial Scope

Gitnux editors write the brief first: the topic, the inclusion rules, and the frame for what belongs.

02Source Research

Agents search the published record and log every extracted figure back to the passage it came from.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 32 days
By 2030, the global proteomics market is projected to reach $35.93 billion, with proteomics services alone forecast at $4.33 billion. Yet growth is not just in revenue, it is visible in the scale of public evidence and workflow adoption, from 19.3 million PSMs deposited in PRIDE to thousands of new ProteomeXchange releases. The contrast between accelerating data generation and the real bottlenecks in analysis and sample prep is exactly where the industry’s next investment decisions are likely to land.

Key Takeaways

  • $35.93 billion global proteomics market size by 2030 — projected total revenue for proteomics products and services
  • $4.33 billion projected proteomics services market size by 2030 — forecast total services revenue
  • $29.9 billion projected proteomics reagents market size by 2030 — forecast revenue
  • The Human Proteome Organization (HUPO) and ProteomeXchange emphasize community-wide deposition requirements; the guideline for minimum data sharing in proteomics supports broader adoption of public datasets across studies
  • The PRIDE database supports uploading of raw mass spectrometry files and processed results; PRIDE’s submission documentation specifies required fields and outputs for proteomics experiments
  • 19.3 million peptide-spectrum matches (PSMs) were deposited in PRIDE as of the stated PRIDE statistics period — indicates breadth of public proteomics MS evidence growth
  • Mass spectrometry-based proteomics is widely used in drug discovery; the FDA’s OpenFDA drug label database contains measurable counts of therapies mentioning biomarkers/omics in label text, reflecting proteomics-enabled biomarker discovery adoption
  • SWATH/DIA library generation supports targeted quantification reuse; peer-reviewed reports show reuse of libraries across experiments to improve identification and quantification consistency
  • 2023: 3.7% of global R&D spending (combined public and private) was allocated to health-related research; proteomics-enabled biomarker/therapeutic development is a major subcomponent — indicates demand-side investment context
  • TMT-based quantification enables multiplexing; TMT labeling formats allow measuring multiple samples in a single run, with channel counts up to 16 in widely used configurations
  • Parallel Reaction Monitoring (PRM) is a targeted MS approach; PRM typically targets specific precursor ions and fragments, improving quantification specificity relative to untargeted methods (quantification specificity is measurable via targeted transitions)
  • Data-independent acquisition (DIA) can quantify hundreds to thousands of proteins in complex samples in a single experiment; peer-reviewed DIA methods papers report proteome-scale quantification outputs
  • 2022: Proteomics/LC-MS/MS equipment costs were a top CAPEX line item in MS lab budgets, representing 25% of instrument-related spend (study budget breakdown) — reflects cost structure faced by adopters
  • 2021: Data analysis labor/time for LC-MS/MS proteomics workflows can account for ~40% of total workflow effort in laboratory operations (workflow breakdown in operational study) — indicates cost pressure and outsourcing demand
  • 2020: Sample preparation costs for proteomics were reported to be a major fraction of per-sample cost (e.g., ~30% in cost-model studies) — drives reagent and services spend

Proteomics is set for rapid growth to $31.0 billion by 2030 as data sharing, mass spectrometry and biomarker adoption accelerate.

Related reading

01 · Category

Market Size12 stats

01
$35.93 billion global proteomics market size by 2030 — projected total revenue for proteomics products and services[1]
02
$4.33 billion projected proteomics services market size by 2030 — forecast total services revenue[1]
03
$29.9 billion projected proteomics reagents market size by 2030 — forecast revenue[1]
04
$4.7 billion projected proteomics instruments market size by 2030 — forecast revenue[1]
05
$2.4 billion projected proteomics software market size by 2030 — forecast revenue[1]
06
$31.0 billion projected proteomics market size by 2030 — forecast total market revenue[2]
07
$5.4 billion projected mass spectrometry market size by 2030 — forecast revenue[2]
08
$7.85 billion projected proteomics market size by 2027 — forecast total market revenue (AMR estimate)[3]
09
U.S. NIH awards supporting proteomics-related research are measurable via NIH RePORTER; queryable counts for proteomics keywords reflect ongoing funding across institute programs[4]
10
2022: 10,000+ instruments installed globally (global instrument install estimate reported in industry analytics) — a measurable scale for installed base supporting proteomics[5]
11
2023: Total U.S. healthcare R&D tax credit impact resulted in billions in additional R&D investment (government estimates) — indirectly supports proteomics-enabled programs[6]
12
2022: Global life sciences research spending reached ~US$1.6 trillion (OECD/industry aggregate figure) — broad underlying spending base for proteomics research services[7]
Interpretation

Market Size Interpretation

By 2030 the proteomics market is projected to reach about $31.0 billion in total revenue, with reagents driving the largest share at $29.9 billion, indicating strong, durable market growth in the market size category.

02 · Category

User Adoption4 stats

01
The Human Proteome Organization (HUPO) and ProteomeXchange emphasize community-wide deposition requirements; the guideline for minimum data sharing in proteomics supports broader adoption of public datasets across studies[8]
02
The PRIDE database supports uploading of raw mass spectrometry files and processed results; PRIDE’s submission documentation specifies required fields and outputs for proteomics experiments[9]
03
19.3 million peptide-spectrum matches (PSMs) were deposited in PRIDE as of the stated PRIDE statistics period — indicates breadth of public proteomics MS evidence growth[9]
04
1,000+ participants submitted data to ProteomeXchange/PRIDE (community size reported in ProteomeXchange documentation) — shows adoption of standardized deposition workflows[10]
Interpretation

User Adoption Interpretation

Under the user adoption angle, ProteomeXchange and PRIDE are clearly winning over the community as 1,000+ participants contribute standardized submissions and PRIDE has accumulated 19.3 million peptide-spectrum matches, showing that more researchers are sharing public proteomics MS evidence through these required workflows.

More related reading

04 · Category

Performance Metrics3 stats

01
TMT-based quantification enables multiplexing; TMT labeling formats allow measuring multiple samples in a single run, with channel counts up to 16 in widely used configurations[17]
02
Parallel Reaction Monitoring (PRM) is a targeted MS approach; PRM typically targets specific precursor ions and fragments, improving quantification specificity relative to untargeted methods (quantification specificity is measurable via targeted transitions)[8]
03
Data-independent acquisition (DIA) can quantify hundreds to thousands of proteins in complex samples in a single experiment; peer-reviewed DIA methods papers report proteome-scale quantification outputs[8]
Interpretation

Performance Metrics Interpretation

Under Performance Metrics, modern mass spectrometry workflows show clear scaling in throughput and specificity, with TMT enabling up to 16-plex quantification per run, PRM providing more targeted quantification through specific precursor and fragment monitoring, and DIA routinely quantifying hundreds to thousands of proteins in a single experiment.

05 · Category

Cost Analysis4 stats

01
2022: Proteomics/LC-MS/MS equipment costs were a top CAPEX line item in MS lab budgets, representing 25% of instrument-related spend (study budget breakdown) — reflects cost structure faced by adopters[13]
02
2021: Data analysis labor/time for LC-MS/MS proteomics workflows can account for ~40% of total workflow effort in laboratory operations (workflow breakdown in operational study) — indicates cost pressure and outsourcing demand[13]
03
2020: Sample preparation costs for proteomics were reported to be a major fraction of per-sample cost (e.g., ~30% in cost-model studies) — drives reagent and services spend[18]
04
2022: Bioinformatics subscription/licensing for proteomics data analysis platforms accounted for 5–15% of lab software budgets (survey-based cost reporting) — shows recurring cost category[13]
Interpretation

Cost Analysis Interpretation

From a cost analysis perspective, proteomics adoption is increasingly shaped by recurring and labor intensive expenses, with LC MS/MS instrument purchases still driving 25% of instrument related CAPEX in 2022 while data analysis alone can consume about 40% of workflow effort in 2021 and bioinformatics licensing adds another 5 to 15% to software budgets in 2022.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Alexander Schmidt. (2026, February 13). Proteomics Industry Statistics. Gitnux. https://gitnux.org/proteomics-industry-statistics
MLA
Alexander Schmidt. "Proteomics Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/proteomics-industry-statistics.
Chicago
Alexander Schmidt. 2026. "Proteomics Industry Statistics." Gitnux. https://gitnux.org/proteomics-industry-statistics.

Sources & references

18 sources cited across this report

  1. fortunebusinessinsights.com
  2. grandviewresearch.com
  3. alliedmarketresearch.com
  4. reporter.nih.gov
  5. frost.com
  6. crsreports.congress.gov
  7. oecd.org
  8. nature.com
  9. ebi.ac.uk
  10. proteomexchange.org
  11. open.fda.gov
  12. fda.gov
  13. sciencedirect.com
  14. uniprot.org
  15. ncbi.nlm.nih.gov
  16. pubs.acs.org
  17. thermofisher.com
  18. pubmed.ncbi.nlm.nih.gov